When a newborn experiences oxygen deprivation during labor or delivery, the effects can extend well beyond those first critical moments. Brain cells that were deprived of oxygen may continue to deteriorate over the hours and days that follow, leading to long-term neurological damage. For parents whose child has experienced a difficult birth, understanding the medical interventions available in those early hours can provide both clarity and hope.

Neonatal therapeutic hypothermia is one of the most significant advances in newborn brain injury care over the past two decades. This treatment offers families a window of opportunity to reduce the severity of brain damage after a hypoxic-ischemic event. While no intervention can reverse all injury, therapeutic hypothermia has been shown to meaningfully improve outcomes for babies born with moderate to severe oxygen deprivation. This page explains what the treatment involves, who qualifies, how it works, and what families can expect during and after the cooling process.

What Neonatal Therapeutic Hypothermia Is and Why It Matters

Neonatal therapeutic hypothermia, often called “cooling therapy” or simply “hypothermia treatment,” is a carefully controlled medical procedure that lowers a newborn’s body temperature to reduce brain injury. It is used specifically for babies who have experienced hypoxic-ischemic encephalopathy (HIE), a type of brain damage caused by insufficient oxygen and blood flow to the brain before, during, or immediately after birth.

When brain cells are deprived of oxygen, they begin to die. But the damage does not stop when oxygen is restored. In the hours following the initial injury, a cascade of harmful processes continues inside the brain, including inflammation, swelling, and further cell death. This secondary phase of injury can sometimes be more damaging than the original oxygen deprivation.

Therapeutic hypothermia works by gently cooling the baby’s body to slow down these harmful processes. Lowering the body’s core temperature reduces the metabolic demands of brain cells, limits inflammation, and decreases the release of toxins that contribute to ongoing injury. The goal is not to eliminate all damage, but to interrupt the progression of injury during that critical window when intervention can still make a difference.

This treatment has become the standard of care in hospitals equipped to provide it, and is one of the few proven therapies that can alter the course of newborn brain injury when administered promptly and appropriately.

Which Babies Qualify for Therapeutic Hypothermia

Not every baby with a difficult birth is a candidate for cooling therapy. Strict medical criteria guide which infants are most likely to benefit, and these guidelines are based on years of clinical research and outcomes data.

Therapeutic hypothermia is recommended for newborns who meet the following conditions:

Born at 36 weeks of gestation or later
Show signs of moderate to severe HIE based on clinical assessment, blood tests, and neurological examination
Can begin cooling within six hours of birth
Do not have other life-limiting conditions or major congenital anomalies that would make cooling unsafe or unlikely to help

The treatment is not typically used for babies born before 35 weeks gestation. Premature infants have different physiological responses to cooling, and research has shown they are at higher risk for complications without clear evidence of benefit.

Babies with only mild signs of HIE are generally not cooled either. Recent studies suggest that cooling does not provide meaningful benefit in cases of mild encephalopathy, and current guidelines do not support its routine use in this group.

Timing is critical. Cooling must begin within the first six hours after birth, and ideally as early as possible within that window. Once the secondary injury cascade is fully underway, cooling is far less effective. This means that birth hospitals and community providers must recognize the signs of HIE quickly and coordinate rapid transfer to a facility capable of providing therapeutic hypothermia.

How the Cooling Process Works

Therapeutic hypothermia is administered in a neonatal intensive care unit (NICU) by a specialized team trained in its use. The process involves careful monitoring and precise temperature control throughout the treatment period.

There are two main methods of cooling. Whole-body cooling uses a cooling blanket or mat placed beneath or around the baby, while selective head cooling uses a cap filled with circulating cold water to cool the brain specifically. Both methods have been shown to be effective in clinical trials, though whole-body cooling is more commonly used today. It is easier to perform, allows for better access to the baby for monitoring and care, and makes it simpler to attach electrodes for continuous brain wave monitoring.

The target temperature for whole-body cooling is typically 33 to 34 degrees Celsius, maintained for 72 hours. This is about five to six degrees below normal body temperature. After the cooling period ends, the baby is slowly rewarmed over a period of six to twelve hours. This gradual rewarming is important because bringing the temperature up too quickly can cause complications or negate some of the treatment’s benefits.

Throughout the 72 hours of cooling and the rewarming phase, the baby is closely monitored. This includes continuous measurement of body temperature, heart rate, blood pressure, oxygen levels, and brain activity using an electroencephalogram, or EEG. Blood tests are repeated regularly to check for side effects and ensure the baby’s organs are functioning properly.

Parents are usually able to stay near their baby during this time, though the cooling equipment and monitoring devices can make the environment feel overwhelming. Nurses and neonatologists work to keep families informed and involved, explaining each step and answering questions as they arise.

The Medical Evidence Supporting Cooling Therapy

Therapeutic hypothermia is not experimental. It is a well-established treatment supported by decades of research and endorsed by major medical organizations including the American Academy of Pediatrics, the Centers for Disease Control and Prevention, and international neonatal care societies.

Clinical trials have consistently shown that cooling reduces the risk of death and severe disability in babies with moderate to severe HIE. Compared to standard supportive care alone, therapeutic hypothermia lowers the combined risk of death or major neurodevelopmental impairment by approximately 24 percent. This includes reduced rates of cerebral palsy, severe cognitive delays, and other long-term disabilities.

Long-term follow-up studies have tracked children who received cooling therapy into early childhood and beyond. These studies confirm that the benefits seen in infancy persist as children grow. Survivors who were cooled are more likely to walk, talk, learn, and live independently than those who did not receive the treatment.

Use of therapeutic hypothermia has grown significantly over the past decade. Data from the Vermont Oxford Network, a national database tracking neonatal care practices, shows that the use of cooling increased by 66 percent between 2012 and 2021. Currently, cooling is provided to approximately 1.1 to 1.5 babies per 1,000 live births in high-resource healthcare systems.

Early initiation remains important. While cooling within six hours is the standard, some evidence suggests that starting within three hours may provide even better outcomes. However, the data does not show a statistically significant difference, and the six-hour window remains the accepted guideline to allow time for assessment, stabilization, and transfer if needed.

Possible Side Effects and When Cooling Is Not Recommended

Like any medical treatment, therapeutic hypothermia carries some risks. However, when performed in an experienced neonatal intensive care unit, these risks are generally manageable and outweighed by the potential benefits.

Side effects that may occur during cooling include:

Slowed heart rate, known as bradycardia
Low platelet count, or thrombocytopenia
Problems with blood clotting, called coagulopathy
Low blood pressure, or hypotension
Irregular heart rhythms, or arrhythmias

These effects are monitored closely, and medical teams are trained to respond if they become concerning. Most resolve on their own once rewarming begins.

Cooling is not appropriate for every baby with HIE. It is not recommended in cases where the baby has:

Severe intrauterine growth restriction
Major congenital anomalies that would limit survival or quality of life
Existing bleeding disorders or severe coagulopathy
Other life-limiting conditions that make intensive intervention inconsistent with the goals of care

Decisions about whether to pursue cooling are made jointly by the medical team and the family, taking into account the baby’s condition, prognosis, and the family’s values and wishes.

What Families Experience During Treatment

For parents, the hours and days following a traumatic birth are often filled with fear, confusion, and uncertainty. Watching your newborn undergo cooling therapy in the NICU can feel isolating, especially when the outcome remains unknown.

Most hospitals encourage parents to be present during the cooling process. While you may not be able to hold your baby in the usual way during the 72 hours of cooling, you can usually touch them, speak to them, and be involved in their care. Many NICUs support skin-to-skin contact and parental participation once rewarming is complete and the baby is stable.

The medical team will provide regular updates about your baby’s condition, what the monitoring shows, and what to expect in the coming hours and days. It is normal to have many questions, and it is important to ask them. Understanding what is happening and why can help parents feel more grounded during a deeply stressful time.

Social workers, chaplains, and parent liaisons are often available to provide emotional support. Some families find comfort in connecting with other parents who have been through similar experiences. Others prefer to focus on their immediate family and take things one day at a time. There is no right way to cope, and hospitals that provide cooling therapy are usually equipped to support families in whatever way feels most helpful.

Long-Term Outcomes and the Need for Follow-Up Care

Therapeutic hypothermia improves outcomes, but it does not guarantee that a child will be unaffected by HIE. Some babies who receive cooling go on to develop normally, while others experience mild to significant developmental delays or disabilities. The severity of the original brain injury, how quickly cooling was started, and other medical factors all play a role in determining long-term outcomes.

Because of this variability, all children who undergo therapeutic hypothermia should receive long-term developmental follow-up. This typically includes assessments at regular intervals through at least the first two years of life, and ideally into the school-age years.

Follow-up care may involve:

Developmental pediatricians who specialize in tracking and supporting children with neurological risks
Physical therapists to address motor delays and movement challenges
Occupational therapists to support skills like feeding, play, and self-care
Speech therapists to help with communication and feeding difficulties
Early intervention programs that provide therapy and support in the home setting

In New York, major medical centers including Mount Sinai, NYU Langone, Columbia University Irving Medical Center, and Albany Medical Center offer specialized neonatal follow-up clinics designed specifically for children who experienced complications at birth. These programs coordinate care across disciplines and help families access the therapies and resources their child needs.

Many hospitals also offer opportunities for families to participate in research studies that track outcomes and test new interventions. Participation is always voluntary, but it can provide access to additional monitoring and support while contributing to the knowledge that will help future families.

Current Medical Guidelines and Ongoing Research

Therapeutic hypothermia is supported by consensus guidelines from leading medical organizations. The American Academy of Pediatrics and international neonatal societies agree on the eligibility criteria, the temperature targets, the duration of cooling, and the importance of careful monitoring and follow-up.

These guidelines emphasize that cooling should only be provided in facilities with the expertise and equipment to do it safely. Birth hospitals and community providers are encouraged to establish transfer protocols so that babies who may benefit from cooling can be moved quickly to a tertiary NICU. Consultation with a neonatologist should occur immediately when HIE is suspected, even before transfer, so that early stabilization and preparation can begin.

Research in this area continues. Scientists are studying whether cooling might be safe and effective in late preterm infants born between 35 and 36 weeks gestation. Others are exploring whether extending the cooling period beyond 72 hours, or combining cooling with other neuroprotective therapies, could further improve outcomes. Studies are also refining the best ways to assess which babies are most likely to benefit and how to provide the most effective follow-up care.

As this research advances, the standards and practices surrounding therapeutic hypothermia will continue to evolve. Families whose children undergo cooling today are benefiting from decades of careful study and the dedication of researchers and clinicians committed to improving outcomes for newborns with brain injuries.

Finding Support and Trusted Information

If your child has experienced HIE and received or is receiving therapeutic hypothermia, know that you are not alone. Thousands of families across the country face similar journeys each year, and many have found strength in connecting with others who understand what it is like to navigate the uncertainty, hope, and grief that can accompany a difficult start to life.

NYBirthInjury.com exists to provide trusted, compassionate information to families affected by birth injuries. This site offers clear explanations of medical conditions and treatments, guidance on finding qualified specialists, and connections to support resources in New York and across the United States. Whether you are still in the NICU or years into your child’s care journey, you deserve access to accurate information and meaningful support.

While no website can replace the guidance of your child’s medical team, having a reliable source of information can help you ask better questions, understand your options, and feel more confident as you make decisions on behalf of your child. You are your child’s strongest advocate, and the more you understand, the better equipped you will be to seek the care and services they need.

Neonatal Therapeutic Hypothermia